Annual Shareholders Equity
$32.52 M
+$32.56 M+86818.67%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual stockholders equity is currently $32.52 million, with the most recent change of +$32.56 million (+86818.67%) on 31 December 2023. During the last 3 years, it has risen by +$32.52 million (+1548647.62%). BLACU annual shareholders equity is now at all-time high.BLACU Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$14.91 M
-$230.90 K-1.52%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly stockholders equity is currently $14.91 million, with the most recent change of -$230.90 thousand (-1.52%) on 30 September 2024. Over the past year, it has dropped by -$17.60 million (-54.14%). BLACU quarterly shareholders equity is now -78.37% below its all-time high of $68.96 million, reached on 30 September 2023.BLACU Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -54.1% |
| 3 y3 years | +10000.0% | +10000.0% |
| 5 y5 years | - | - |
BLACU Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -78.4% | >+9999.0% |
| 5 y | 5 years | at high | >+9999.0% | -78.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -78.4% | >+9999.0% |
Bellevue Life Sciences Acquisit Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.91 M(-1.5%) |
| June 2024 | - | $15.15 M(-53.3%) |
| Mar 2024 | - | $32.46 M(-0.2%) |
| Dec 2023 | $32.52 M | $32.52 M(-52.8%) |
| Sept 2023 | - | $68.96 M(+0.1%) |
| June 2023 | - | $68.88 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $68.58 M(<-9900.0%) |
| Dec 2022 | -$37.50 K(+1685.7%) | - |
| Dec 2022 | - | -$37.50 K(+60.9%) |
| Sept 2022 | - | -$23.30 K(+628.1%) |
| June 2022 | - | -$3200.00(+52.4%) |
| Dec 2021 | -$2100.00(-275.0%) | -$2100.00 |
| Dec 2020 | $1200.00 | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual stockholders equity?
- What is the all time high annual shareholders equity for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly shareholders equity year-on-year change?
What is Bellevue Life Sciences Acquisit annual stockholders equity?
The current annual shareholders equity of BLACU is $32.52 M
What is the all time high annual shareholders equity for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual stockholders equity is $32.52 M
What is Bellevue Life Sciences Acquisit quarterly stockholders equity?
The current quarterly shareholders equity of BLACU is $14.91 M
What is the all time high quarterly shareholders equity for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly stockholders equity is $68.96 M
What is Bellevue Life Sciences Acquisit quarterly shareholders equity year-on-year change?
Over the past year, BLACU quarterly stockholders equity has changed by -$17.60 M (-54.14%)